trial · primary record
Baxdrostat
Uncontrolled Hypertension
| Phase | Phase 3 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 796 |
| Primary completion | 2025-10-10 |
| Primary endpoint | Change From Baseline in Seated Systolic Blood Pressure for 2 mg Baxdrostat |
| Registry ID | NCT06034743 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:59.336Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06034743
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Baxdrostat · approval
- Baxdrostat · compound